Please assess the completion status of the following clinical trial:

Trial Title: Compassion Meditation and ReliefLink App for Suicidal, Low-Income, African Americans

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* self-identify as African American or Black~* speak English~* present to medical and psychiatric emergency rooms at Grady Health System following a suicide attempt~* moderate level of intent associated with the attempt (SSI \>= 8 required)~* Mini Mental State Exam (MMSE) score \> 22~Exclusion Criteria:~* significant cognitive impairments (MMSE \< 22)~* active psychosis (diagnosed based on Psychotic Screen (PS))~* imminently life-threatening medical condition

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Study Arms:
- Compassion meditation (CM) (Type: EXPERIMENTAL): The CM participants will attend six weekly sessions (each 120 minute), and will be video and/or audiotaped. Each weekly CM session will entail a 30 minute check-in regarding the participants' levels of suicidal ideation, as well as a discussion of current life stress and weekly meditation practice; a 30 minute didactic session that will describe the meditative technique introduced during the week; and a 30 minute guided meditation session. Participants will be encouraged to meditate at least 30 minutes a day and will be asked to track their daily meditation time and bring in their tracking sheet to each session.
- Support group (SG) (Type: ACTIVE_COMPARATOR): SG participants will attend six weekly sessions, 90 minutes in length. It will be unstructured. Participants will use this time to talk about current concerns and to receive support and guidance from other group members and the leaders.

Based on this trial design, predict the completion outcome and termination type (if applicable).